These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 28410843

  • 1. Left ventricular hypertrophy does not prevent heart failure in experimental hypertension.
    Hernán Gómez Llambí H, Cao G, Donato M, Suárez D, Ottaviano G, Müller A, Buchholz B, Gelpi R, Otero-Losada M, Milei J.
    Int J Cardiol; 2017 Jul 01; 238():57-65. PubMed ID: 28410843
    [Abstract] [Full Text] [Related]

  • 2. Modulation of left and right ventricular beta-adrenergic receptors from spontaneously hypertensive rats with left ventricular hypertrophy and failure.
    Atkins FL, Bing OH, DiMauro PG, Conrad CH, Robinson KG, Brooks WW.
    Hypertension; 1995 Jul 01; 26(1):78-82. PubMed ID: 7607736
    [Abstract] [Full Text] [Related]

  • 3. Losartan inhibits the post-transcriptional synthesis of collagen type I and reverses left ventricular fibrosis in spontaneously hypertensive rats.
    Varo N, Etayo JC, Zalba G, Beaumont J, Iraburu MJ, Montiel C, Gil MJ, Monreal I, Díez J.
    J Hypertens; 1999 Jan 01; 17(1):107-14. PubMed ID: 10100101
    [Abstract] [Full Text] [Related]

  • 4. Attenuation of cardiac failure, dilatation, damage, and detrimental interstitial remodeling without regression of hypertrophy in hypertensive rats.
    Tsotetsi OJ, Woodiwiss AJ, Netjhardt M, Qubu D, Brooksbank R, Norton GR.
    Hypertension; 2001 Oct 01; 38(4):846-51. PubMed ID: 11641297
    [Abstract] [Full Text] [Related]

  • 5. The cardiopulmonary reflexes of spontaneously hypertensive rats are normalized after regression of left ventricular hypertrophy and hypertension.
    Uggere TA, Abreu GR, Sampaio KN, Cabral AM, Bissoli NS.
    Braz J Med Biol Res; 2000 May 01; 33(5):589-94. PubMed ID: 10775891
    [Abstract] [Full Text] [Related]

  • 6. Involvement of pentraxin-3 in the development of hypertension but not left ventricular hypertrophy in male spontaneously hypertensive rats.
    Mkhize SA, Manilall A, Mokotedi L, Gunter S, Michel FS.
    Physiol Rep; 2024 Oct 01; 12(20):e70086. PubMed ID: 39414396
    [Abstract] [Full Text] [Related]

  • 7. PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats.
    Bartha E, Solti I, Kereskai L, Lantos J, Plozer E, Magyar K, Szabados E, Kálai T, Hideg K, Halmosi R, Sumegi B, Toth K.
    Cardiovasc Res; 2009 Aug 01; 83(3):501-10. PubMed ID: 19443425
    [Abstract] [Full Text] [Related]

  • 8. [Effect of chronic antihypertensive treatment on ischemia-induced lethal ventricular tachyarrhythmias and electrophysiological property in hypertrophied rat hearts].
    Yokoshiki H.
    Hokkaido Igaku Zasshi; 1993 Nov 01; 68(6):862-72. PubMed ID: 8112711
    [Abstract] [Full Text] [Related]

  • 9. Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats.
    Takeda K, Fujita H, Nakamura K, Uchida A, Tanaka M, Itoh H, Nakata T, Sasaki S, Nakagawa M.
    Blood Press Suppl; 1994 Nov 01; 5():94-8. PubMed ID: 7889211
    [Abstract] [Full Text] [Related]

  • 10. PARP-inhibitor treatment prevents hypertension induced cardiac remodeling by favorable modulation of heat shock proteins, Akt-1/GSK-3β and several PKC isoforms.
    Deres L, Bartha E, Palfi A, Eros K, Riba A, Lantos J, Kalai T, Hideg K, Sumegi B, Gallyas F, Toth K, Halmosi R.
    PLoS One; 2014 Nov 01; 9(7):e102148. PubMed ID: 25014216
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
    Ikeda Y, Nakamura T, Takano H, Kimura H, Obata JE, Takeda S, Hata A, Shido K, Mochizuki S, Yoshida Y.
    J Lab Clin Med; 2000 Apr 01; 135(4):353-9. PubMed ID: 10779052
    [Abstract] [Full Text] [Related]

  • 12. Effect of carvedilol on pulse pressure and left ventricular hypertrophy in spontaneously hypertensive rats with adriamycin nephropathy.
    Jovanovic D, Jovovic D, Mihailovic-Stanojevic N, Miloradovic Z, Naumovic R, Dimitrijevic J, Maksic N, Djukanovic L.
    Biomed Pharmacother; 2009 Sep 01; 63(8):571-6. PubMed ID: 19013753
    [Abstract] [Full Text] [Related]

  • 13. Chronic enalapril treatment increases transient outward potassium current in cardiomyocytes isolated from right ventricle of spontaneously hypertensive rats.
    Rodrigues Junior LF, de Azevedo Carvalho AC, Pimentel EB, Mill JG, Nascimento JH.
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Mar 01; 390(3):225-234. PubMed ID: 27915452
    [Abstract] [Full Text] [Related]

  • 14. Progressive impairment of atrial myocyte function during left ventricular hypertrophy and heart failure.
    Pluteanu F, Nikonova Y, Holzapfel A, Herzog B, Scherer A, Preisenberger J, Plačkić J, Scheer K, Ivanova T, Bukowska A, Goette A, Kockskämper J.
    J Mol Cell Cardiol; 2018 Jan 01; 114():253-263. PubMed ID: 29191788
    [Abstract] [Full Text] [Related]

  • 15. Age-related difference in cardiac adaptation to chronic hypertension in rats, with and without nifedipine treatment.
    Raizada V, Pathak D, Skipper B, Nakouzi A, Malhotra A.
    Mol Cell Biochem; 1999 Aug 01; 198(1-2):109-12. PubMed ID: 10497884
    [Abstract] [Full Text] [Related]

  • 16. Liver growth factor treatment restores cell-extracellular matrix balance in resistance arteries and improves left ventricular hypertrophy in SHR.
    Conde MV, Gonzalez MC, Quintana-Villamandos B, Abderrahim F, Briones AM, Condezo-Hoyos L, Regadera J, Susin C, Gomez de Diego JJ, Delgado-Baeza E, Diaz-Gil JJ, Arribas SM.
    Am J Physiol Heart Circ Physiol; 2011 Sep 01; 301(3):H1153-65. PubMed ID: 21642499
    [Abstract] [Full Text] [Related]

  • 17. Blockade of angiotensin II provides additional benefits in hypertension- and ageing-related cardiac and vascular dysfunctions beyond its blood pressure-lowering effects.
    Demirci B, McKeown PP, Bayraktutan U.
    J Hypertens; 2005 Dec 01; 23(12):2219-27. PubMed ID: 16269964
    [Abstract] [Full Text] [Related]

  • 18. Role of cardiac hypertrophy in reducing the sensitivity of cardiopulmonary reflex control of renal sympathetic nerve activity in spontaneously hypertensive rats.
    de Andrade TU, Abreu GR, Moysés MR, de Melo Cabral A, Bissoli NS.
    Clin Exp Pharmacol Physiol; 2008 Sep 01; 35(9):1104-8. PubMed ID: 18788121
    [Abstract] [Full Text] [Related]

  • 19. [A treatment with rosuvastatin induced a reduction of arterial pressure and a decrease of oxidative stress in spontaneously hypertensive rats].
    Sicard P, Lauzier B, Oudot A, Busseuil D, Collin B, Duvillard L, Moreau D, Vergely C, Rochette L.
    Arch Mal Coeur Vaiss; 2005 Sep 01; 98(7-8):804-8. PubMed ID: 16220751
    [Abstract] [Full Text] [Related]

  • 20. Improvement in fatty acid utilization in relation to a change in left ventricular hypertrophy in spontaneously hypertensive rats.
    Ono T, Kohya T, Tsukamoto E, Mochizuki T, Itoh K, Itoh Y, Tomita F, Tamaki N, Kitabatake A.
    Jpn Circ J; 2000 Feb 01; 64(2):117-20. PubMed ID: 10716525
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.